Visufarma, first LTD then a joint-stock company from 2006, is a pharmaceutical company founded in 1996.

The ophthalmic market is its core business.

Its product portfolio includes several products to treat not only acute ophthalmic pathologies but also chronic and evolutive pathologies.

Visufarma has 53 employers among which 37 Representatives -"ISF"- working throughout the territory.

The Company values equal opportunities: both men and women work as "ISF" who earned the university degrees envisaged by the decree of the Ministry of  Public Health.
Scientific and personnel training are carefully planned in order to guarantee that the information offered is documented, objective and has a solid scientific background.

Our VISION is to constantly improve making the company one of the most important in the ophthalmic market in Italy.

Our MISSION is to invest in the Research to obtain new products for both chronic and acute eye diseases in order to improve patient's quality of life.

This Profit will allow available funds for the Research, guaranteeing the job to its employers and also the shareholders remuneration.

Visufarma plans to expand its business to specialized markets: it already has a list but a further development of new products is being planned thanks to the introduction of new molecules and formulations.

For this reason, Visufarma plans to create a new DIVISION to increase its business and new opportunities.

The collaboration between Ursapharm and Visufarma has allowed Visufarma to introduce and distribute the Comod^® Patented System into the Italian market.